Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy (Q33859549)

29 July 2017

1 reference

title

Expression and function of EGF-related peptides and their receptors in gynecological cancer--from basic science to therapy (English)

1 reference

29 July 2017

Ebert AD

1

1 reference

29 July 2017

Wechselberger C

2

1 reference

29 July 2017

Martinez-Lacaci I

3

1 reference

29 July 2017

Bianco C

4

1 reference

29 July 2017

Weitzel HK

5

1 reference

29 July 2017

Salomon DS

6

1 reference

29 July 2017

1 January 2000

1 reference

Journal of Receptors and Signal Transduction

29 July 2017

1 reference

29 July 2017

20

1 reference

29 July 2017

1

1 reference

29 July 2017

1-46

1 reference

Growth factors and cancer

29 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Structure-function relationships for the EGF/TGF-alpha family of mitogens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Specificity within the EGF family/ErbB receptor family signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Cancer of the Uterine Cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Antisense human papillomavirus (HPV) E6/E7 expression, reduced stability of epidermal growth factor, and diminished growth of HPV-positive tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Aetiology, pathogenesis, and pathology of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Interactions of the human papillomavirus E7 protein with cell cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Insulin-like growth factor II mediates epidermal growth factor-induced mitogenesis in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal-growth-factor receptor correlates negatively with cell density in cervical squamous epithelium and is down-regulated in cancers of the human uterus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Localization of human epidermal growth factor receptor in cervical intraepithelial neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Prognostic value of c-erbB-2 expression in uterine cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Prognostic value of epidermal growth factor receptor expression in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Immunohistochemical investigation and northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The epidermal growth factor receptor in the human endometrial adenocarcinoma cell line HEC-1-B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Regulation of PTP1D mRNA by peptide growth factors in the human endometrial cell line HEC-1-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor receptor expression and endometrial cancer histotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Effects of LHRH-analogues on mitogenic signal transduction in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Cross talk between peptide growth factor and estrogen receptor signaling systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Menstrual cycle specific expression of epidermal growth factor receptors in human fallopian tube epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Clinical significance of oncogenes and growth factors in ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Growth factors in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Growth factors in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Transforming growth factor-alpha and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Estrogen regulation of transforming growth factor-alpha in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Absence of constitutive EGF receptor activation in ovarian cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The prognostic value of epidermal growth factor receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Expression of the ErbB family of receptors in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Expression of epidermal growth factor and androgen receptors in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Overexpression of the oncogene c-erbB-2 (HER2/neu) in ovarian cancer: a new prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Activation of c-erbB-2 and prognosis in ovarian carcinoma. Comparison with histologic type, grade, and stage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor receptor and c-erbB-2 oncoproteins in tissue and tumor effusion cells of histopathologically different ovarian neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Type I receptor tyrosine kinases as targets for therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Immunologic approaches to inhibiting cell-surface-residing oncoproteins in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Immunoconjugates made of an anti-EGF receptor monoclonal antibody and type 1 ribosome-inactivating proteins from Saponaria ocymoides or Vaccaria pyramidata

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Herceptin raises its sights beyond advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The c-erbB transmembrane growth factor receptors as serum biomarkers in human cancer studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Novel anticancer agents move closer to reality.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

The potential of farnesyltransferase inhibitors as cancer chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Signal transduction. How receptors turn Ras on.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Epidermal growth factor-like modules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10799890009150035

10.3109/10799890009150035

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference